Cargando…

Profiling of Substrate Specificity of SARS-CoV 3CL(pro)

BACKGROUND: The 3C-like protease (3CL(pro)) of severe acute respiratory syndrome-coronavirus is required for autoprocessing of the polyprotein, and is a potential target for treating coronaviral infection. METHODOLOGY/PRINCIPAL FINDINGS: To obtain a thorough understanding of substrate specificity of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chuck, Chi-Pang, Chong, Lin-Tat, Chen, Chao, Chow, Hak-Fun, Wan, David Chi-Cheong, Wong, Kam-Bo
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2950840/ https://www.ncbi.nlm.nih.gov/pubmed/20949131 http://dx.doi.org/10.1371/journal.pone.0013197

Ejemplares similares

Profiling of Substrate Specificities of 3C-Like Proteases from Group 1, 2a, 2b, and 3 Coronaviruses
por: Chuck, Chi-Pang, et al.
Publicado: (2011)

Design, synthesis and crystallographic analysis of nitrile-based broad-spectrum peptidomimetic inhibitors for coronavirus 3C-like proteases
por: Chuck, Chi-Pang, et al.
Publicado: (2013)

Mechanistic insights into COVID-19 by global analysis of the SARS-CoV-2 3CL(pro) substrate degradome
por: Pablos, Isabel, et al.
Publicado: (2021)

Novel Blue- and Red-Shifted Internally Quenched Fluorogenic Substrates for Continuous Monitoring of SARS-CoV 3CL(pro)
por: Hamill, Pamela, et al.
Publicado: (2006)

Protocol for production and purification of SARS-CoV-2 3CL(pro)
por: Mazzei, Luca, et al.
Publicado: (2023)

Identification of Darunavir Derivatives for Inhibition of SARS-CoV-2 3CL(pro)
por: Ma, Ling, et al.
Publicado: (2022)

No Substrate Left behind—Mining of Shotgun Proteomics Datasets Rescues Evidence of Proteolysis by SARS-CoV-2 3CL(pro) Main Protease
por: Bell, Peter A., et al.
Publicado: (2023)

In Silico Substrate-Binding Profiling for SARS-CoV-2 Main Protease (M(pro)) Using Hexapeptide Substrates
por: Zabo, Sophakama, et al.
Publicado: (2023)

Biflavonoids from Torreya nucifera displaying SARS-CoV 3CL(pro) inhibition
por: Ryu, Young Bae, et al.
Publicado: (2010)

Inhibition of the SARS-CoV-2 3CL(pro) main protease by plant polyphenols
por: Bahun, Miha, et al.
Publicado: (2022)

Machine learning prediction of 3CL(pro) SARS-CoV-2 docking scores
por: Bucinsky, Lukas, et al.
Publicado: (2022)

Prioritisation of Compounds for 3CL(pro) Inhibitor Development on SARS-CoV-2 Variants
por: Jukič, Marko, et al.
Publicado: (2021)

Expression of SARS-coronavirus spike glycoprotein in Pichia pastoris
por: Chuck, Chi-Pang, et al.
Publicado: (2008)

Virtual high throughput screening: Potential inhibitors for SARS-CoV-2 PL(PRO) and 3CL(PRO) proteases
por: Jade, Dhananjay, et al.
Publicado: (2021)

Gain-of-Signal Assays for Probing Inhibition of SARS-CoV-2 M(pro)/3CL(pro) in Living Cells
por: Moghadasi, Seyed Arad, et al.
Publicado: (2022)

In silico screening of potential compounds from begonia genus as 3CL protease (3Cl pro) SARS-CoV-2 inhibitors
por: Maulana, Saipul, et al.
Publicado: (2023)

Molecular dynamic simulations analysis of ritronavir and lopinavir as SARS-CoV 3CL(pro) inhibitors
por: Nukoolkarn, Veena, et al.
Publicado: (2008)

Human Superantibodies to 3CL(pro) Inhibit Replication of SARS-CoV-2 across Variants
por: Glab-ampai, Kittirat, et al.
Publicado: (2022)

Repurposing of HIV/HCV protease inhibitors against SARS-CoV-2 3CL(pro)
por: Ma, Ling, et al.
Publicado: (2022)

In silico analysis of echinocandins binding to the main proteases of coronaviruses PEDV (3CL(pro)) and SARS-CoV-2 (M(pro))
por: Vergoten, Gérard, et al.
Publicado: (2021)

Design, synthesis, and evaluation of trifluoromethyl ketones as inhibitors of SARS-CoV 3CL protease
por: Shao, Yi-Ming, et al.
Publicado: (2008)

New developments for the design, synthesis and biological evaluation of potent SARS-CoV 3CL(pro) inhibitors
por: Regnier, Thomas, et al.
Publicado: (2009)

Studies on the interactions of Ti-containing polyoxometalates (POMs) with SARS-CoV 3CL(pro) by molecular modeling
por: Hu, Donghua, et al.
Publicado: (2007)

SARS-CoV 3CL(pro) inhibitory effects of quinone-methide triterpenes from Tripterygium regelii
por: Ryu, Young Bae, et al.
Publicado: (2010)

Crystallographic models of SARS-CoV-2 3CL(pro): in-depth assessment of structure quality and validation
por: Jaskolski, Mariusz, et al.
Publicado: (2021)

Discovery of chebulagic acid and punicalagin as novel allosteric inhibitors of SARS-CoV-2 3CL(pro)
por: Du, Ruikun, et al.
Publicado: (2021)

Design, synthesis and in vitro evaluation of novel SARS-CoV-2 3CL(pro) covalent inhibitors
por: Stille, Julia K., et al.
Publicado: (2022)

The Repurposed Drugs Suramin and Quinacrine Cooperatively Inhibit SARS-CoV-2 3CL(pro) In Vitro
por: Eberle, Raphael J., et al.
Publicado: (2021)

Screening of drugs by FRET analysis identifies inhibitors of SARS-CoV 3CL protease
por: Liu, Yu-Chih, et al.
Publicado: (2005)

Engineering a novel endopeptidase based on SARS 3CL(pro)
por: Kuo, Chih-Jung, et al.
Publicado: (2009)

Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CL (pro)) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates
por: Chen, Yu Wai, et al.
Publicado: (2020)

Characterization of host substrates of SARS-CoV-2 main protease
por: Melano, Ivonne, et al.
Publicado: (2023)

Pro108Ser mutation of SARS-CoV-2 3CL(pro) reduces the enzyme activity and ameliorates the clinical severity of COVID-19
por: Abe, Kodai, et al.
Publicado: (2022)

An overview of potential inhibitors targeting non-structural proteins 3 (PL(pro) and Mac1) and 5 (3CL(pro)/M(pro)) of SARS-CoV-2
por: Yan, Fangfang, et al.
Publicado: (2021)

Investigation of changes in protein stability and substrate affinity of 3CL-protease of SARS-CoV-2 caused by mutations
por: Akbulut, Ekrem
Publicado: (2022)

SARS-CoV-2 polyprotein substrate regulates the stepwise M(pro) cleavage reaction
por: Narwal, Manju, et al.
Publicado: (2023)

Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL(pro) Reporter Assay
por: Froggatt, Heather M., et al.
Publicado: (2020)

Identification of Vitamin K3 and its analogues as covalent inhibitors of SARS-CoV-2 3CL(pro)
por: Wang, Ruyu, et al.
Publicado: (2021)

A Bioluminescent 3CL(Pro) Activity Assay to Monitor SARS-CoV-2 Replication and Identify Inhibitors
por: Mathieu, Cyrille, et al.
Publicado: (2021)

Dual targeting of 3CL(pro) and PL(pro) of SARS-CoV-2: A novel structure-based design approach to treat COVID-19
por: Rajpoot, Sajjan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hlcvn043mdglbtreerjoiv87e4